Category Archive: Social Media

Feb 25

Will Social Media Kill the Placebo Trial?

By David Gee, Strategic Business Developer at Cato Research In the past, patients participating on drug trials had very little chance to communicate with other participants. With the increasing use of social media, not only between people all over the world with common disease interests, but now also between participants on specific trials comparing notes, …

Continue reading »

Jun 25

Clinical Trials in the Facebook Age

On 07 Jun 2011, Pfizer initiated a clinical trial pilot to assess safety and efficacy of Detrol LA, which is a treatment for overactive bladder (OAB).  The trial, REMOTE (Research on Electronic Monitoring of OAB Treatment Experience), was the first completely “virtual” trial ever designed.   The trial was set-up to compare if a completely virtual …

Continue reading »

Mar 30

Social Media in Clinical Trials: Increasing Patient Recruitment

Sources used to access health and wellness information

When you become sick with a virus or are seeking information about a diet, where’s the first place that you turn to for help? Is it the doctor’s office or the internet? A recent study showed that the percentage of American adults that had access to the internet rose from 46% in 2000 to 74% …

Continue reading »

Jul 08

Check Out Our New Blog Design

Image via Wikipedia If you’re reading this, then you’re also seeing our new blog design.  We’ve replaced the previous WordPress theme (Pearl, available here) with a customized version of the Twenty Ten 1.0 theme that was recently released with WordPress 3.0. Our goal for the redesign was a simple, clean look that is easy to …

Continue reading »

Jun 28

Novel Approaches to Clinical Trial Recruitment

Traditional patient recruitment strategies like print, television and radio ads are relatively expensive and much less effective than targeted online advertisement.  Eighty percent of Americans who are online are now searching for health information (Allison, 2009), including avenues to participate in clinical trials.  Biotech and Pharmaceutical companies are taking advantage of the rise in social …

Continue reading »

May 14

Advice from the FDA, Part 2: Making Your eCTD Submission Reviewer-Friendly

Cato’s Director of Regulatory Operations, Evan Richardson, authored a guest blog post featured on PharmPro.com today.  PharmPro.com is the website for Pharmaceutical Processing magazine, offering a wealth of  information on products, technologies and applications for pharmaceutical and biopharmaceutical professionals. Evan’s post, “Advice from the FDA, Part 2: Making Your eCTD Submission Reviewer-Friendly,” offers practical advice …

Continue reading »

Apr 09

White House Issues Memo on Federal Agencies and Social Media

It isn’t necessary to imagine the world ending in fire or ice. There are two other possibilities: one is paperwork, and the other is nostalgia. – Frank Zappa The White House Office of Information and Regulatory Affairs just released a memo titled:  Social Media, Web-Based Interactive Technologies, and the Paperwork Reduction Act.  Unfortunately, the title …

Continue reading »

Apr 08

Advice from the FDA, Part 1: Technical Errors to Avoid in Your eCTD Submissions

Cato’s Director of Regulatory Operations, Evan Richardson, authored a guest blog post featured on PharmPro.com today.  PharmPro.com is the website for Pharmaceutical Processing magazine, offering a wealth of  information on products, technologies and applications for pharmaceutical and biopharmaceutical professionals. Evan’s post, “Advice from the FDA, Part 1: Technical Errors to Avoid in Your eCTD Submissions,” …

Continue reading »